| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/28/2005 | EP1580556A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 09/28/2005 | EP1580555A1 Magnetic particle collecting magnetic force body and its use |
| 09/28/2005 | EP1580554A1 Method of immobilizing polynucleotide on solid support, solid immobilization support thus obtained, method of detecting target polynucleotide from the solid support and solution for immobilizing polynucleotide |
| 09/28/2005 | EP1580553A1 Method of assaying elastin digestion product and assay kit, method of detecting aortic dissection and detection kit |
| 09/28/2005 | EP1580552A1 Microfluidic analytical system with position electrodes |
| 09/28/2005 | EP1580551A1 Plasma or serum separation membrane and filter apparatus including the plasma or serum separation membrane |
| 09/28/2005 | EP1580550A2 Method of determining a property characteristic for the viscosity of a combustion engine oil |
| 09/28/2005 | EP1580544A1 Examining device for water resistant, air-permeable cloth |
| 09/28/2005 | EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma |
| 09/28/2005 | EP1580279A1 Method of measuring lipid in specific lipoprotein |
| 09/28/2005 | EP1580271A2 Human Orphan G Protein-Coupled Receptors |
| 09/28/2005 | EP1580269A1 Method of detecting gene mutation |
| 09/28/2005 | EP1580266A1 Screening method |
| 09/28/2005 | EP1580265A1 Nucleic acids isolated from neuroblastoma at stage 4s |
| 09/28/2005 | EP1580196A1 Monitor protein for measuring processing of protein |
| 09/28/2005 | EP1579926A2 Apparatus supplying liquid drops to predetermined positions on a substrate |
| 09/28/2005 | EP1579506A2 Water soluble metal and semiconductor nanoparticle complexes |
| 09/28/2005 | EP1579383A2 Binary prediction tree modeling with many predictors and its uses in clinical and genomic applications |
| 09/28/2005 | EP1579373A2 Optical tomography of small objects using parallel ray illumination and post-specimen optical magnification |
| 09/28/2005 | EP1579223A2 Transport device for transporting test strips in an analysis system |
| 09/28/2005 | EP1579222A1 Non-competitive immunoassay for small analytes |
| 09/28/2005 | EP1579221A2 Uses of hmgb, hmgn, hmga proteins |
| 09/28/2005 | EP1579220A2 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer |
| 09/28/2005 | EP1579219A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 2c (5-ht2c) |
| 09/28/2005 | EP1579218A2 Method of modulation of interaction between receptor and ligand |
| 09/28/2005 | EP1579217A1 Method of determining site-specificity and kit therefor |
| 09/28/2005 | EP1579216A2 Loc169505 as modifier of the apc and axin pathways and methods of use |
| 09/28/2005 | EP1579215A2 Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates |
| 09/28/2005 | EP1579214A2 Methods of screening for anti-inflammatory drugs and use thereof |
| 09/28/2005 | EP1579213A1 Method of diagnosis,treatment and useful agents for conditions characterised by modulation in the level of activin beta c. |
| 09/28/2005 | EP1579212A2 Methods of identifying reduced internalization transmembrane receptor agonists |
| 09/28/2005 | EP1579211A1 Microporous filtration based dot immunoassay device for method for screening of analytes and method of use |
| 09/28/2005 | EP1579210A1 Colorimetric sensors constructed of diacetylene materials |
| 09/28/2005 | EP1579209A2 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 09/28/2005 | EP1579208A1 Analyzing system for the detection of reducing and oxidizing gases in a carrier gas with a metal-oxide-semiconductor sensor arrangement |
| 09/28/2005 | EP1579207A2 Measurement of total reactive isocyanate groups in samples using bifunctional nucleophiles such as 1,8-diaminonaphthalene (dan) |
| 09/28/2005 | EP1579204A1 Manufacture of electrochemical sensors by moveable flat screen printing |
| 09/28/2005 | EP1579194A2 Enhanced scheduling sample processing system and methods of biological slide processing |
| 09/28/2005 | EP1579191A2 Method and apparatus for separation of particles in a microfluidic device |
| 09/28/2005 | EP1579188A2 Semipermeable membrane-based sampling systems |
| 09/28/2005 | EP1579186A2 Identification of kinase inhibitors |
| 09/28/2005 | EP1579013A2 Method for profiling and identifying persons by using data samples |
| 09/28/2005 | EP1579012A2 Monitoring high-risk environments |
| 09/28/2005 | EP1579010A2 Susceptibility gene for myocardial infarction; methods of treatment |
| 09/28/2005 | EP1579004A2 Screening methods for identification of efficient pre-trans-splicing molecules |
| 09/28/2005 | EP1579000A1 Magnetism based nucleic acid amplification |
| 09/28/2005 | EP1578999A2 Molecules and methods using same for measuring non-transferrin bound iron |
| 09/28/2005 | EP1578994A2 Methods for identifying dna copy number changes |
| 09/28/2005 | EP1578993A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 09/28/2005 | EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions |
| 09/28/2005 | EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 09/28/2005 | EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 09/28/2005 | EP1578982A2 Nucleic acid amplification methods |
| 09/28/2005 | EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof |
| 09/28/2005 | EP1578980A2 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 09/28/2005 | EP1578962A2 Carrier-ligand fusions and uses thereof |
| 09/28/2005 | EP1578961A2 Bindingzyme arrays and high-throughput proteomic methods |
| 09/28/2005 | EP1578960A1 Magnetism based rapid cell separation |
| 09/28/2005 | EP1578950A2 Methods for crystallographic structure determination employing hydrogen exchange analysis |
| 09/28/2005 | EP1578948A2 Flj10607 as modifier of the axin pathway and methods of use |
| 09/28/2005 | EP1578945A2 Cct6s as modifiers of the rb pathway and methods of use |
| 09/28/2005 | EP1578941A2 Csnks as modifiers of the rac pathway and methods of use |
| 09/28/2005 | EP1578940A2 Methods and compositions for diagnosing dysplasia |
| 09/28/2005 | EP1578934A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 09/28/2005 | EP1578931A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 09/28/2005 | EP1578929A2 Nematode phosphoethanolamine n-methyltransferase-like sequences |
| 09/28/2005 | EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/28/2005 | EP1578923A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 09/28/2005 | EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 09/28/2005 | EP1578921A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 09/28/2005 | EP1578920A2 Composition and method for modulating an inflammatory response |
| 09/28/2005 | EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578911A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 09/28/2005 | EP1578910A2 Nitrilases |
| 09/28/2005 | EP1578906A2 Afap sequences, polypeptides, antibodies and methods |
| 09/28/2005 | EP1578904A2 Systems, methods and kits for remote genetic analysis and consultation |
| 09/28/2005 | EP1578903A2 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 09/28/2005 | EP1578902A2 Neurotransmission-associated proteins |
| 09/28/2005 | EP1578899A2 Secreted proteins |
| 09/28/2005 | EP1578896A2 Electro-optical nucleic acid-based sensor array and method for detecting analytes |
| 09/28/2005 | EP1578799A2 Antibodies directed to tumor necrosis factor and uses thereof |
| 09/28/2005 | EP1578798A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 09/28/2005 | EP1578794A1 A novel phosphoprotein |
| 09/28/2005 | EP1578793A1 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
| 09/28/2005 | EP1578781A2 Process for determining target function and identifying drug leads |
| 09/28/2005 | EP1578778A2 Ghrelin analogs |
| 09/28/2005 | EP1578775A2 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange |
| 09/28/2005 | EP1578773A2 Methods and products based on oligomerization of stress proteins |
| 09/28/2005 | EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity |
| 09/28/2005 | EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof |
| 09/28/2005 | EP1578687A2 Crystalline structure of human mapkap kinase-2 |
| 09/28/2005 | EP1578612A2 Ink composition for use in a continuous web process for the manufacture of electrochemical sensors |
| 09/28/2005 | EP1578527A1 Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays |
| 09/28/2005 | EP1578456A1 Isotope labeled camptothecin derivatives |
| 09/28/2005 | EP1578446A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 09/28/2005 | EP1578444A2 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 09/28/2005 | EP1578411A1 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 09/28/2005 | EP1578397A2 Human monoclonal antibodies against cd25 |